Albemarle
Valuation each multiple against its own 5-year range
Vs. peers Specialty Chemicals
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Albemarle (ALB) | 9.41B | 19.20 | 1.13 | 2.04% |
| Linde (LIN) | 230.84B | 33.39 | 5.86 | 1.25% |
| Ecolab (ECL) | 82.65B | 40.10 | 7.93 | 0.99% |
| Sherwin-Williams (SHW) | 82.08B | 31.25 | 20.64 | 0.94% |
| Air Products & Chemicals (APD) | 66.16B | 124.31 | 4.63 | 2.43% |
| PPG Industries (PPG) | 25.87B | 16.71 | 3.05 | 2.45% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 138.4% below Morningstar's fair value estimate.
Analyst note
Albemarle reported strong third-quarter results, as adjusted EBITDA nearly tripled year over year due almost entirely to higher lithium prices. The shares were up more than 3% on Nov. 5.
Why it matters: Albemarle's average realized lithium price was over $19,500 per metric ton in the quarter. This is notable, as it is around our long-term midcycle estimate of $20,000 per metric ton. Energy storage EBITDA margins around 50% confirm our view that Albemarle is a low-cost lithium producer that can generate strong profits in a midcycle environment. Albemarle's low-cost lithium production underpins our Narrow Morningstar Economic Moat Rating.
The bottom line: We've reduced our fair value estimate to $190 per share from $200. We view Albemarle shares as materially undervalued, trading nearly 50% below our fair value estimate and in 5-star territory. The shares are down almost 60% from their 52-week high as lithium spot and futures prices have fallen and now sit at roughly $13,000 per metric ton. However, we still see demand outpacing supply this year, moving the market closer to balance and driving prices higher. For investors who can withstand the volatility, we see strong upside relative to downside for Albemarle. The shares trade less than 10% above our downside scenario, which produces a fair value estimate of $90. This scenario assumes long-term lithium prices average $10,000 per metric ton, or half of our base case.
Between the lines: The reduction in our fair value estimate was driven by our outlook for lower near-term lithium prices. This reflects our updated near-term price forecasting, which is informed by futures prices. We also lowered our capital expenditure forecast as Albemarle is becoming more efficient in its sustaining capex. This partially offset the impact of lower lithium prices.
Fair value
We have reduced our fair value estimate to $190 per share from $200 after third-quarter results. The reduction is driven by our outlook for lower near-term lithium prices. This reflects our updated near-term price forecasting, which is informed by futures prices. We also lowered our capital expenditure forecast as Albemarle is becoming more efficient in its sustaining capex. This partially offset the impact of lower lithium prices.
We assume a roughly 10% weighted average cost of capital. We use a multiple of 11 times midcycle EBITDA to value free cash flows generated beyond our 10-year explicit forecast horizon.
Lithium will remain Albemarle's largest business. Lithium carbonate spot prices, which tend to be a leading indicator of contract prices, are currently around $13,000 per metric ton (based on published indexes), up from $8,000 per metric ton in mid-2025. Prices rose as demand outpaced supply over 2025 and into 2026. As demand growth remains strong and global supply growth slows, we expect the market to remain closer to balance in 2026.
In the longer term, we expect lithium prices to remain volatile but to average around the marginal cost of production, which we estimate at approximately $20,000 per metric ton. Our price forecast is based on our forecast for the marginal cost of lithium production on an all-in sustaining cost basis. We expect lithium demand to grow at nearly a 20% annual rate from around 1.6 million metric tons in 2025 to 3.2 million metric tons by 2030. By 2030, approximately 95% of lithium demand is expected to come from batteries that require high-quality lithium with minimal impurities. To meet demand, higher-cost supply will need to come online from lower-quality resources that will require higher processing costs.
In response to the price downturn, Albemarle scaled back its lithium growth projects. As a result, we forecast Albemarle's lithium sales volumes will grow to just over 300,000 metric tons by 2030, up from over 230,000 metric tons in 2025. Regardless, Albemarle's focus on cost reductions should enable it to benefit significantly from additional volume sold, and we expect lithium to remain its highest-margin segment.
We forecast that specialties (bromine and nonbattery lithium) will see higher profits in 2026 due to the Middle East conflict-related supply shock to bromine, benefiting Albemarle's US operation. Longer-term, demand for brominated flame retardants should grow due to increased 5G devices, Internet of Things technology, servers, and increased content per vehicle in automobile electronics.
Our forecast includes the company's divestiture of a 51% stake in its Ketjen catalysts business for $660 million.
Regarding the preferred equity shares, given our fair value estimate is well above the maximum conversion price of $131.268, we assume the preferred shares convert at the maximum conversion price in March 2027. For every $1,000 in preferred shares, there are 7.618 shares of common stock. The preferred shares will trade on a depository basis, with each depository share being equal to 1/20 of a preferred share. The preferred shares carry a 7.25% annual dividend.
Given the wide range of potential lithium prices, we see a range of outcomes for Albemarle. In a lower-for-longer pricing scenario, we forecast lithium prices to average $10,000 per metric ton in 2026 real terms over the next decade. We also assume very little volume over the next decade. In this scenario, our fair value estimate would be $90 per share.
In a higher pricing scenario, we forecast lithium prices to average over $20,000 per metric ton in 2026 real terms over the remainder of the 2020s, generating profits and free cash flow well above our base case. In this scenario, our fair value estimate would be $400 per share.
Economic moat
We award a Narrow Morningstar Economic Moat Rating to Albemarle for the company’s strong and durable cost advantage in lithium and bromine production.
Globally, lithium carbonate is produced from either lower-cost evaporation of brine or higher-cost mining of spodumene minerals. Albemarle has a cost advantage in lithium carbonate production due to its lucrative brine assets in the Salar de Atacama in Chile, which produce lithium at the lowest cost globally, excluding royalties.
Two factors make the Salar de Atacama the lowest-cost source of lithium: dry conditions and high lithium concentration. The Salar de Atacama is one of the driest places in the world and the largest salt flat in Chile. It has an extremely high evaporation rate and low rainfall. Snow from the Andes melts and flows underground into pools of brine, which have the highest concentration of lithium globally. This high concentration makes the company one of the lowest-cost lithium producers even among brine-based producers. The company pumps the brine above ground into a network of large evaporation ponds. Water evaporates from the ponds over the course of approximately 18 months, leaving behind concentrated lithium brine, which is then processed into lithium derivatives, including lithium carbonate and lithium hydroxide for batteries. Albemarle has a contract through 2043 with the Chilean government to extract around 80,000 metric tons of lithium per year.
Albemarle’s lithium carbonate produced from the Salar de Atacama has the lowest cash cost in the world. However, the Chilean government implements one of the highest royalties globally, in a progressive scheme that in the highest bracket sets a 40% rate on prices over $10,000 per metric ton. At $20,000, which is our current view of the marginal cost of production, this amounts to a 27% royalty rate. Because of the royalty expense, neither Albemarle nor SQM, which also operates at the Salar de Atacama, is the lowest-cost producer if lithium prices are $20,000 per metric ton or higher. However, for a cost advantage moat source, we look at an operation’s ability to generate an excess return on invested capital when prices are at the bottom of a cycle. When lithium prices are below $14,000 per metric ton, the royalty is greatly reduced, and the geological advantage of the Salar de Atacama puts Albemarle and SQM firmly at the bottom of the cost curve. As a result, we view Albemarle’s Chilean brine as having a durable cost advantage.
Albemarle also has lithium brine assets in Silver Peak, Nevada. While not as advantaged as the prime Chilean asset due to lower lithium concentration, this Nevada asset still sits on the lower half of the lithium carbonate cost curve.
Albemarle owns a 49% joint-venture interest in Talison's operations in Greenbushes, Western Australia. The Talison mine produces spodumene, a hard rock mineral extracted through traditional mining methods, that is the feedstock converted into a downstream lithium product. Albemarle produces lithium hydroxide from two vertically integrated low-cost spodumene mines.
Lithium hydroxide can be produced directly from spodumene, whereas brine-based operations must first produce carbonate and then convert to hydroxide. Although lithium hydroxide has traditionally made up a small portion of total lithium demand, electric vehicle batteries will increasingly use lithium hydroxide as hydroxide-based battery chemistries generally allow EVs to have a greater range than lithium carbonate. As a result, we expect lithium hydroxide demand will see strong growth as EV adoption increases.
The Talison operation is the highest-quality spodumene deposit in the world and sits on the low end of the lithium hydroxide cost curve, owing to its geological advantage. Talison's spodumene has roughly double the lithium concentration of other high-quality spodumene deposits around the world. Given that Albemarle is a fully integrated producer using Talison spodumene as its feedstock, we view its lithium hydroxide business as moatworthy based on a durable cost advantage in lithium hydroxide production.
Albemarle has a second spodumene operation in Western Australia in a joint venture with Mineral Resources. This is also fully integrated, with Albemarle producing hydroxide from its Wodgina spodumene. Wodgina spodumene is high-quality with a low-cost position, albeit above Talison. Accordingly, while hydroxide made from Wodgina spodumene will not be as low-cost as hydroxide made from Talison spodumene, the Wodgina operation will still sit on the low end of the lithium hydroxide cost curve.
Albemarle's advantaged position in bromine comes from its low-cost and long-lived assets in the Dead Sea and Arkansas. Production costs are largely determined by concentration, as higher concentration means that less water needs to be evaporated to produce bromine from brine. The Dead Sea is the lowest-cost bromine source, with concentrations of 10,000 parts per million, while Arkansas has concentrations of 5,000 parts per million. These assets have 2.5-5.0 times the concentration of the next-best reserves in India and 25-50 times the concentration of producers in China. Albemarle's Arkansas asset has more than 70 years of reserves remaining. The Dead Sea, for all intents and purposes, is an inexhaustible asset, given its enormous reserves compared with production volume. Albemarle's Dead Sea production comes from its 50% interest in Jordan Bromine, which it operates with Arab Potash.
All in all, we think Albemarle’s strong and durable cost advantage in lithium and bromine makes it more likely than not that the company will outearn its cost of capital over at least the next decade.
Bull case
Albemarle has top-tier lithium assets through its brine operations in Chile and spodumene hard rock operations in Western Australia, which are among the lowest-cost sources of lithium production globally.
Lithium prices will rebound then remain well above the marginal cost of production through at least the remainder of the decade, leading to excess profits and return on invested capital for Albemarle.
Albemarle has low-cost bromine production through its highly concentrated brines in the Dead Sea and Arkansas.
Bear case
Lithium prices will fall and remain lower for longer as new supply growth will outpace demand, weighing on profitability.
Albemarle's investment in higher-cost lithium resources, including Wodgina and King's Mountain, will prove value-destructive as they will not generate returns above its weighted average cost of capital.
Chile's plan to nationalize lithium could result in Albemarle being forced to trade a majority stake to the government to renew its lease, destroying shareholder value.
By Seth Goldstein, CFA
Quote time 2026-11-20 20:02:16 · For reference only, not investment advice and not tailored to your situation.
Albemarle discussion 0 comments